Curis, Inc. (CRIS)
0.4534
-0.02
(-3.41%)
USD |
NASDAQ |
Nov 20, 09:49
Curis Free Cash Flow : -30.77M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -30.77M |
| June 30, 2026 | -30.59M |
| March 31, 2026 | -28.95M |
| December 31, 2025 | -27.20M |
| September 30, 2025 | -30.09M |
| June 30, 2025 | -30.46M |
| March 31, 2025 | -33.58M |
| December 31, 2024 | -39.56M |
| September 30, 2024 | -40.49M |
| June 30, 2024 | -42.73M |
| March 31, 2024 | -39.47M |
| December 31, 2023 | -38.43M |
| September 30, 2023 | -40.52M |
| June 30, 2023 | -45.51M |
| March 31, 2023 | -50.13M |
| December 31, 2022 | -54.75M |
| September 30, 2022 | -50.66M |
| June 30, 2022 | -47.09M |
| March 31, 2022 | -41.27M |
| December 31, 2021 | -37.62M |
| September 30, 2021 | -35.18M |
| June 30, 2021 | -31.61M |
| March 31, 2021 | -30.34M |
| December 31, 2020 | -26.42M |
| September 30, 2020 | -26.28M |
| Date | Value |
|---|---|
| June 30, 2020 | -28.13M |
| March 31, 2020 | -24.90M |
| December 31, 2019 | -26.25M |
| September 30, 2019 | -25.59M |
| June 30, 2019 | -25.94M |
| March 31, 2019 | -30.71M |
| December 31, 2018 | -30.15M |
| September 30, 2018 | -32.76M |
| June 30, 2018 | -41.03M |
| March 31, 2018 | -43.39M |
| December 31, 2017 | -48.54M |
| September 30, 2017 | -50.44M |
| June 30, 2017 | -41.54M |
| March 31, 2017 | -43.34M |
| December 31, 2016 | -36.14M |
| September 30, 2016 | -37.56M |
| June 30, 2016 | -34.48M |
| March 31, 2016 | -30.16M |
| December 31, 2015 | -29.94M |
| September 30, 2015 | -23.79M |
| June 30, 2015 | -21.37M |
| March 31, 2015 | -19.37M |
| December 31, 2014 | -16.90M |
| September 30, 2014 | -17.72M |
| June 30, 2014 | -15.45M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lineage Cell Therapeutics, Inc. | -26.46M |
| Agenus, Inc. | -103.86M |
| Amgen, Inc. | 9.581B |
| Anika Therapeutics, Inc. | 2.295M |
| BioCryst Pharmaceuticals, Inc. | 348.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.749M |
| Cash from Financing (Quarterly) | 5.69M |
| Free Cash Flow Per Share (Quarterly) | -1.376 |
| Free Cash Flow to Equity (Quarterly) | -5.445M |
| Free Cash Flow to Firm (Quarterly) | -5.749M |
| Free Cash Flow Yield | -1.65K% |